Company announcement – No. 28 / 2022
Credit Suisse Group AG has notified Zealand about a change of its total holding of shares and voting rights, in accordance with section 38 of the Capital Markets Act, and other financial instruments according to section 39(2)(1) of the Capital Markets Act and financial instruments with similar economic effect according to section 39(2)(2) of the Capital Markets Act, such that it now holds below the 5% threshold of share capital and voting rights attached to shares of Zealand.
Please see further details in the attached notification form.
# # #
About
Zealand was founded in 1998 in
Forward-Looking Statement
The above information contains forward-looking statements that provide Zealand Pharma’s expectations or forecasts of future events. Such forward-looking statements are subject to risks, uncertainties and inaccurate assumptions, which may cause actual results to differ materially from expectations set forth herein and may cause any or all of such forward-looking statements to be incorrect. If any or all of such forward-looking statements prove to be incorrect, our actual results could differ materially and adversely from those anticipated or implied by such statements. All such forward-looking statements speak only as of the date of this release and are based on information available to
For further information, please contact:
Zealand Pharma Investor Relations |
investors@zealandpharma.com |
Zealand Pharma Media Relations |
media@zealandpharma.com |
Attachment
- 220603_signed_Zealand Pharma_Standardformular engelsk
Source:
2022 GlobeNewswire, Inc., source